Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: Extracorporeal Shockwave Therapy for the Treatment of Chronic Angina Pectoris [Phase 1]
Phase 1 trial of Extracorporeal Shockwave Therapy for refractory angina pectoris has been suspended.
-
CLINICAL_TRIALS withdrawal · 2012-02-17Clinical Trial Update: Comparison Of Left Ventricular Volume And Wall Stress With Dobutamine And Exercise Echocardiography
A clinical trial comparing left ventricular volume and wall stress using dobutamine versus exercise echocardiography has been withdrawn.
-
FDA approval · 2012-01-27FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for propranolol hydrochloride from Ipca Laboratories Limited, finalizing a regulatory update for the…
-
FDA approval · 2012-01-27FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)
FDA approved Endo USA, Inc.'s supplemental application for propranolol hydrochloride, indicating the generic product's supplemental filing h…
-
FDA approval · 2012-01-17FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for atenolol from Aurobindo Pharma Limited, sanctioning a generic Atenolol product. This approva…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-01-10Clinical Trial Update: Genetic Mapping for Cardiac Risk Assessment
An ongoing genetic mapping trial intended to assess cardiac risk. The current status of the study is unknown.
-
FDA approval · 2011-12-31FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for amlodipine besylate from Aurobindo Pharma Limited, confirming continued approval of this generic…
-
FDA approval · 2011-12-31FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
The FDA approved a supplemental application for amlodipine besylate from Teva Pharmaceuticals, Inc. Amlodipine besylate is used to treat hyp…
-
FDA approval · 2011-12-31FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Archis Pharma LLC)
The FDA approved a supplemental application for nicardipine hydrochloride from Archis Pharma LLC, approving the generic product under the AN…
-
FDA approval · 2011-12-15FDA Approved: METOPROLOL SUCCINATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved METOPROLOL SUCCINATE as a generic via an Original Application (ANDA) for Mylan Pharmaceuticals Inc.
-
FDA approval · 2011-11-28FDA Approved: ATENOLOL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for generic atenolol from Rising Pharma Holdings, Inc. under the ANDA.
-
FDA approval · 2011-11-28FDA Approved: FELODIPINE — Original Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's felodipine generic tablet under an Original Application (ANDA 202170). Felodipine is a ca…
-
FDA approval · 2011-11-14FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
FDA approved a supplemental application for Verapamil hydrochloride submitted by Teva Pharmaceuticals Inc. This action finalizes changes to …
-
FDA approval · 2011-11-02FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)
FDA approved a supplemental NDA for Verapamil Hydrochloride from Exela Pharma Sciences, LLC under NDA 018925.
-
FDA approval · 2011-10-31FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC, resulting in an approved label…
-
FDA approval · 2011-10-28FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s supplemental application for CARTIA XT (diltiazem hydrochloride) under ANDA074752.
-
FDA approval · 2011-10-28FDA Approved: FELODIPINE — Original Application (Endo USA, Inc.)
FDA approves Endo USA, Inc.'s original application for Felodipine (generic), a calcium channel blocker for hypertension and angina.
-
FDA approval · 2011-10-25FDA Approved: ATENOLOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Atenolol from Teva Pharmaceuticals USA, Inc. This action updates the regulatory status of the ge…
-
FDA approval · 2011-10-18FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for atenolol submitted by Aurobindo Pharma Limited, granting regulatory approval for the supplem…
-
CLINICAL_TRIALS trial_result · 2011-10-07Clinical Trial Update: The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization [NA]
This completed clinical trial evaluated the effect of clopidogrel on coated platelets in patients undergoing cardiac catheterization, with r…
-
CLINICAL_TRIALS trial_result · 2011-09-30Clinical Trial Update: Adenosine Cardioplegia; Improved Cardioprotection? [Phase 1, Phase 2]
Phase 1/2 trial evaluating adenosine-based cardioplegia for improved cardioprotection in angina pectoris has completed.
-
FDA approval · 2011-09-27FDA Approved: PROCARDIA XL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for PROCARDIA XL (nifedipine) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2011-09-13FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for Atenolol by Zydus Lifesciences Limited under an ANDA, authorizing an approved supplemental actio…
-
FDA approval · 2011-08-31FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for amlodipine besylate from Aurobindo Pharma Limited, authorizing continued marketing of the ge…
-
FDA approval · 2011-08-29FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (TruPharma LLC)
The FDA approved a supplemental application for bisoprolol fumarate by TruPharma LLC, under an ANDA.